International Survey of Trials of Convalescent Plasma to Treat COVID-19 InfectionReview article Published on 2020-07-012022-10-05 Journal: Transfusion Medicine Reviews [Category] SARS, 임상, [키워드] Antibody testing Antibody titer authors Case series CCP clinical trial registry clinical trials Clinical use conducted Contact convalescent plasma country COVID-19 COVID-19 infection Critical care cut-off Donor dose eligibility criteria greater Hospitalization individuals Infection International majority non-infected Patient provide Randomized controlled trial RCT RCTs recruit secondary outcome sick similarity survey therapy for COVID-19 Variability variety were blinded [DOI] 10.1016/j.tmrv.2020.06.003 [Article Type] Review article
Letter to the editor: efficacy of different methods of combination regimen administrations including dexamethasone, intravenous immunoglobulin, and interferon-beta to treat critically ill COVID-19 patients: a structured summary of a study protocol for a randomized controlled trialLetter Published on 2020-06-192022-10-29 Journal: Trials [Category] Coronavirus, SARS, [키워드] 24 hours acute respiratory distress administration Admission age age and sex allergy ARDS Arm blinded Blood oxygen saturation can be used checked clinical coded Combination combination regimen Computed tomography conducted Contact Control control arm Corticosteroid Corticosteroids COVID-19 COVID-19 patients Critically ill Critically ill patient critically ill patients Cytokine storm develop Dexamethasone dissemination dosage dose drug early administration education Efficacy element eligible excessive inflammatory response experimental group Frequency generate group help hepatitis B HIV positive hospital Hospitalization hospitalized patient Hypothesis Immunoglobulin IMPROVE increase in Inflammation information Interferon-beta Intervention intervention group Intravenous immunoglobulin intubation investigator Iran laboratory technician less lung lung damage management mortality rate MOST number Nurses objective outcome Parallel Arm participant Patient patients Patients management percentage positive RT-PCR Pregnancy protocol random random number generator randomised randomised controlled trial randomization Randomized controlled trial Randomly RCT receive reduce Registration reported researcher respiratory rate Sample size severe COVID-19 Side effects Standard standard treatment statistical statistician study drug study group Study protocol subject supportive care syndrome the cytokine storm the WHO treat Treatment Trial website WHO guideline [DOI] 10.1186/s13063-020-04499-5 PMC 바로가기 [Article Type] Letter
A randomized controlled trial of antibody response to 2018–19 cell-based vs. egg-based quadrivalent inactivated influenza vaccine in children ☆Article Published on 2020-06-122023-06-23 Journal: Vaccine [Category] 신종인플루엔자, [키워드] adolescents children immunogenicity Influenza RCT Vaccine [DOI] 10.1016/j.vaccine.2020.06.023 PMC 바로가기 [Article Type] Article
Efficacy and safety of Anluohuaxian in the treatment of patients with severe Coronavirus disease 2019- a multicenter, open label, randomized controlled study: a structured summary of a study protocol for a randomised controlled trialLetter Published on 2020-06-082022-10-29 Journal: Trials [Category] Coronavirus, SARS, [키워드] 6-minute walking distance actual Alpha analyst Anluohuaxian antiviral drugs brand bronchial asthma Care change changes Chinese Chinese herbal medicines chronic obstructive Colchicine Combined completion Compliance composed computer tomography Confirmed connective tissue control group Coronavirus disease 2019 COVID-19 criteria Cyclophosphamide cytokine diagnosed dissemination distribution drug Efficacy and safety element Endocrine enrolled Estimated evaluate expected experimental group explained facilitate fibrosis glucocorticoid groups hepatic fibrosis High-resolution history Hormones HRCT Huoshenshan Hospital Imatinib include indicate interferon-γ interstitial Interstitial lung disease investigators involved IWRS Kidney disease lactating liver lobular lung maximum Mental Disorders minimum multicenter Nasopharyngeal swab Necrosis negative neurologic Nintedanib nodule not blinded nucleic acid test number objective open label outcome outcome assessors participant Participants Pathogenesis pathway Patient pharmaceutical pill professional proportion protocol provided pulmonary pulmonary disease pulmonary fibrosis random randomised randomised controlled trial randomization randomization system Randomized Randomized controlled trial randomly divided RCT recruitment Research research drug respiratory specimen Sample size Science second selected severe COVID-19 sputum statistical status Study protocol subject technology therapeutic drug Tongji Hospital treated Treatment treatment group Trial Union Hospital university variety website West Wuhan Year [DOI] 10.1186/s13063-020-04399-8 PMC 바로가기 [Article Type] Letter
Umbilical cord blood therapy to prevent progression of COVID-19 related pneumonia: a structured summary of a study protocol for a pilot randomised controlled trialLetter Published on 2020-06-042022-10-29 Journal: Trials [Category] Coronavirus, SARS, [키워드] 1:1 24 hour acute COVID-19 administration Anti-inflammatory ARDS block Blood blood cell Cell cells clinical Clinical improvement control group Cord blood COVID-19 COVID-19 patients dissemination dose Efficacy element Estimated feasibility feasible hospitalised patient immunomodulatory properties infected with SARS-CoV-2 injection intravenous Melbourne, Australia moderate New number objective occur outcome participant Patient Placebo Pneumonia Prevent progression protocol randomised randomised controlled trial RCT recruit recruitment Registered registry Safety Sample size SARS-COV-2 infection sealed severe ARDS severe pneumonia Standard status stem cells Study protocol supportive care therapy Tolerability Total Treatment Trial Umbilical cord umbilical cord blood virus website [DOI] 10.1186/s13063-020-04387-y PMC 바로가기 [Article Type] Letter
A short, animated video to improve good COVID-19 hygiene practices: a structured summary of a study protocol for a randomized controlled trialLetter Published on 2020-06-032022-10-29 Journal: Trials [Category] Coronavirus, SARS, [키워드] 1:1 age Algorithm anonymously APC Arm avoidance Behavioral intent behavioural blinded changes in clinical component control arm control group country COVID-19 COVID-19 outbreak Developed dissemination Effect Effectiveness Effects element eligible English Entertainment-education excluded expected experiment Face masks female FIVE France French Germany Gorilla highest Host hygiene IMPROVE include Interaction Intervention intervention arm investigator investigators item knowledge List experiment male media Medicine Novel coronavirus number objective outcome outcome measure parallel group participant Participants physical contact Placebo platform Prevalence Prevent Primary outcome Prolific Academic protocol question questionnaire randomised controlled trial randomization randomize Randomized Randomized controlled trial Randomly RCT reached receive recruit recruited reduce Registered secondary outcome sequence Sex social distancing Spain Spanish Spread spread of COVID-19 Stanford Study protocol submitted The United States total sample size Treatment treatment group Trial United Kingdom was collected washing hand washing hands website [DOI] 10.1186/s13063-020-04449-1 PMC 바로가기 [Article Type] Letter
The need of health policy perspective to protect Healthcare Workers during COVID-19 pandemic. A GRADE rapid review on the N95 respirators effectivenessResearch Article Published on 2020-06-032022-10-28 Journal: PLoS ONE [Category] COVID-19, MERS, SARS, [키워드] 95% CI 95%CI Bacterial catastrophic CDC Cochrane Library COVID-19 pandemic COVID-19 patient ECDC Effectiveness evaluate Evidence HCW HCWs Health Healthcare system high quality evidence identify influenza like illness laboratory-confirmed Mask N95 respirator pandemic Perspective Prevent prevention of COVID-19 PROTECT Protecting protective effect Randomized controlled trial RCT RCTs recommendations Resilience respiratory respiratory infection respiratory infections respiratory viral infections routine care SARS-CoV-2 SARS-CoV-2 pandemic searched Support surgical the SARS-CoV-2 Trial was used WHO worker [DOI] 10.1371/journal.pone.0234025 PMC 바로가기 [Article Type] Research Article
Controlled, double-blind, randomized trial to assess the efficacy and safety of hydroxychloroquine chemoprophylaxis in SARS CoV2 infection in healthcare personnel in the hospital setting: A structured summary of a study protocol for a randomised controlled trialLetter Published on 2020-06-032022-10-29 Journal: Trials [Category] Coronavirus, SARS, [키워드] 1:1 95% CI absence addition administration of hydroxychloroquine Admission aerosol-generating procedures allergy analyzed Anesthesia antibody approved ARMS assigned balanced randomization blind Cancer Cantabria carried CDC Cell Chemoprophylaxis clinical Clinical data clinically coated Committee comparator Comparator group computer-generated control group Controlled Controlled clinical trial Controlled trial coronavirus COVID COVID-19 criteria CURB current detect Determination disease dissemination double blind double-blind dropout rate Efficacy Efficacy and safety element ELISA kit Emergency Endocrine estimate Ethics Euroimmun Evidence evidence of Germany GRADE greater group Health Health authority health-care healthcare personnel Healthcare professional healthcare professionals heart heart failure help hematological high risk hospital Hydroxychloroquine hydroxychloroquine sulfate hygiene Hypothesis ICU IDT IgA IgG IgM and IgG immune immunodeficiency in vitro incidence include Infection inhibit intensive care unit Intervention investigator kidney lactation liver measure Measures Medicine Negative PCR neurological New York number observation period outcome participant PCR performed Personal protective equipment Placebo positive positive SARS-CoV-2 PCR positive serology Pregnancy presenting Prevalence Primary outcome probes product professional Prophylaxis Prospective PROTECT Protective protocol Psychiatric randomised randomised controlled trial randomization Randomized randomized trial RCT receive recruitment reduce reported responsible risk RT-PCR Sample size SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 PCR sequence Seroconversion serological serology severity Significant single center single-center study social distancing Spain Spanish Standard Statistical power status Study protocol subject Support Symptom symptomatic and asymptomatic Tablet Takara Taking Tamoxifen Transmission Treatment two-tailed university Vaccine virus website while [DOI] 10.1186/s13063-020-04400-4 PMC 바로가기 [Article Type] Letter
Herbal Medicine for the Treatment of Coronavirus Disease 2019 (COVID-19): A Systematic Review and Meta-Analysis of Randomized Controlled TrialsReview Published on 2020-05-232022-10-30 Journal: Journal of Clinical Medicine [Category] COVID-19, [키워드] 95% CI 95% confidence interval adverse event calculated caused CIs Combined therapy complementary and alternative medicine Controlled Controlled trial coronavirus disease cough COVID-19 data extraction database Effect effect size effective Effectiveness eligible evaluate fatigue Fever Herbal herbal medicine independent Medicine Odds ratio outbreak pandemic Patient performed RCT RCTs reported Respiratory illness review risk of bia risk ratio RRs searched Serious Adverse Event Significant significantly sore throat sputum production Symptom syndrome systematic review TCM treating COVID-19 Treatment Trial was used [DOI] 10.3390/jcm9051583 PMC 바로가기 [Article Type] Review
Shining a light on the evidence for hydroxychloroquine in SARS-CoV-2Commentary Published on 2020-04-282022-11-01 Journal: Critical Care [Category] COVID-19, SARS, [키워드] COVID-19 Evidence Evidence-based medicine Hydroxychloroquine pandemic RCT SARS SARS-CoV-2 [DOI] 10.1186/s13054-020-02894-7 PMC 바로가기 [Article Type] Commentary